LABD Fact Sheet: Direxion Daily S&P Biotech Bear 3X ETF
Share
$7.42
close, Nov 13, 2026
Over the year to Nov 13, 2026, LABD returned −72.8% in total and charged 1.07% a year.
- 1-year total return
- −72.8%
- XBI +35.1% to Nov 13, 2026
- Expense ratio
- 1.07%
- a year
- Net assets
- $79m
- on Nov 12, 2026
- Net flow, last 5 trading days
- +$29.3m
- daily basis to Nov 12, 2026
Growth of $10,000, 1 year
LABD $2,721 −72.8% · XBI $13,509 +35.1% · Total return, distributions reinvested, Nov 13, 2025 to Nov 13, 2026.
Returns
WindowTotal return
1 month−14.1%
3 months−0.9%
Year to date−64.0%
1 year−72.8%
3 years−96.0%
Total return, distributions reinvested, each window to Nov 13, 2026.
Facts
Aims to return three times the opposite of the daily move of biotech (XBI) · First traded May 28, 2015 · Benchmark XBI